Is the Prophylactic Use of Hepatoprotectants Necessary in Anti-Tuberculosis Treatment?

Publisher： Karger

E-ISSN： 1421-9794|62|5|269-278

ISSN： 0009-3157

Source： Chemotherapy, Vol.62, Iss.5, 2017-05, pp. : 269-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Tuberculosis Drugs and Human Polymorphonuclear Leukocyte Functions

By  

Chemotherapy, Vol. 57, Iss. 4, 2011-09 ,pp. : 339-344

Karger

Access to resources Recommend Favorite

Synthesis and Anti-Tuberculosis Activity of the Marine Natural Product Caulerpin and Its Analogues

By Canché Chay Cristina I.   Gómez Cansino Rocío   Espitia Pinzón Clara I.   Torres-Ochoa Rubén O.   Martínez Roberto  

Marine Drugs, Vol. 12, Iss. 4, 2014-03 ,pp. : 1757-1772

MDPI

Access to resources Recommend Favorite

Protective Effect of Bicyclol on Anti-Tuberculosis Drug Induced Liver Injury in Rats

By Liu Xin   Zhao Manman   Mi Jiaqi   Chen Hui   Sheng Li   Li Yan  

Molecules, Vol. 22, Iss. 4, 2017-04 ,pp. : 524-524

MDPI

Access to resources Recommend Favorite

Phloretin Exerts Anti-Tuberculosis Activity and Suppresses Lung Inflammation

By Jeon Dasom   Jeong Min-Cheol   Jnawali Hum Nath   Kwak Chulhee   Ryoo Sungwon   Jung In Duk   Kim Yangmee  

Molecules, Vol. 22, Iss. 1, 2017-01 ,pp. : 183-183

MDPI

Access to resources Recommend Favorite

Evaluation of Killing Kinetics of Anti-Tuberculosis Drugs on Mycobacterium tuberculosis Using a Bacteriophage-Based Assay

By  

Chemotherapy, Vol. 54, Iss. 5, 2008-09 ,pp. : 404-411

Karger

Access to resources Recommend Favorite